Skip to main content

TD Asset Management Inc

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1056053 Toronto, A6

Position in HALO

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$87,328,187
+$11,797,304 QoQ
Shares Held
1,115,730
-4.5% QoQ
Ownership
0.983%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#33
of 664 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. HALO ranks #3 (7.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 HALO
Halozyme Therapeutics, Inc.
This page
1,115,730 $87,328,187

All Filings in HALO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $87,328,187 1,115,730
2026-03-31 $75,530,883 1,168,666
2025-12-31 $62,703,679 931,704
2025-09-30 $75,919,367 1,035,170
2025-06-30 $56,741,335 1,090,760
2025-03-31 $92,642,038 1,451,842
2024-12-31 $65,601,726 1,372,134
2024-09-30 $88,764,128 1,550,736
2024-06-30 $123,882,869 2,365,983
2024-03-31 $103,378,700 2,541,266
2023-12-31 $73,325,535 1,983,916
2023-09-30 $12,282,293 321,526
2023-06-30 $11,597,442 321,526
2023-03-31 $12,279,077 321,526
2022-12-31 $10,406,156 182,885
2020-06-30 $530,838 19,800